| HS Code | 729720 |
| Product Name | Dimethyl fumarate |
| Active Ingredient | Dimethyl fumarate |
| Chemical Name | Dimethyl (E)-but-2-enedioate |
| Molecular Formula | C6H8O4 |
| Molecular Weight | 144.13 g/mol |
| Cas Registry Number | 624-49-7 |
| Drug Class | Immunomodulator; fumaric acid ester |
| Mechanism Of Action | Activates the Nrf2 pathway and may reduce lymphocyte counts |
| Approved Indications | Relapsing forms of multiple sclerosis; moderate-to-severe plaque psoriasis in some regions |
| Dosage Forms | Delayed-release capsules; gastro-resistant tablets |
| Route Of Administration | Oral |
| Typical Dosing | Multiple sclerosis: 120 mg twice daily for 7 days, then 240 mg twice daily; psoriasis dosing varies by regional labeling |
| Brand Names | Tecfidera; Fumaderm combination products; generic products |
| Storage | Store at controlled room temperature; protect from light and moisture according to labeling |
| Appearance | Capsules or tablets; raw material is a white to off-white powder |
| Solubility | Slightly soluble in water; soluble in organic solvents |
| Prescription Status | Prescription-only medicine |
As an accredited Dimethyl Fumarate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Dimethyl Fumarate is supplied in a sealed 25 kg fiber drum with an inner polyethylene liner, clearly labeled and moisture-protected. |
| Container Loading (20′ FCL) | Dimethyl Fumarate loaded in a 20′ FCL container, palletized in drums, securely strapped and shrink-wrapped for safe ocean transport. |
| Shipping | Dimethyl Fumarate is shipped as a white crystalline solid in sealed, moisture-resistant containers. Store in a cool, dry, well-ventilated area away from light and oxidizers. Handle with PPE, avoiding dust inhalation and skin/eye contact. It is generally not classified as dangerous goods for transport. |
| Storage | Store dimethyl fumarate in a cool, dry, well-ventilated area in a tightly closed, labeled container. Protect from moisture, heat, direct sunlight, and ignition sources. Keep away from strong oxidizing agents and incompatible chemicals. Use secondary containment where appropriate, maintain inventory and SDS access, and ensure storage is secure and inaccessible to unauthorized persons. |
| Shelf Life | Dimethyl fumarate typically has a shelf life of about 2–3 years when stored dry, sealed, and protected from light at room temperature. |
Monograph-grade dimethyl fumarate (CAS 624-49-7) enters the pharmaceutical downstream through isolator-contained solids handling and dry granulation for delayed-release oral capsules. The crystalline API is first jet-milled; laser diffraction testing per USP <429> is used to verify a volume mean diameter below 20 µm and a D90 below 40 µm, because sub-20 µm particle size reduces segregation in low-dose blends and improves dissolution in pH 6.8 phosphate buffer after the enteric coating disintegrates. The powder blend contains microcrystalline cellulose, croscarmellose sodium, colloidal silicon dioxide, and magnesium stearate; roller compaction is preferred for this API because dimethyl fumarate is prone to punch filming during direct compression at tableting speeds above 40 rpm on rotary presses. The granules are compressed into microtablets and functional-coated in a perforated pan coater with methacrylic acid–ethyl acrylate copolymer (USP/NF, type C) dispensed at 12–18% solids. Inlet air temperature is held at 40–50 °C, exhaust air humidity below 2.0 g/kg, and pan speed adjusted to maintain tablet surface temperature below 25 °C to avoid amorphous phase inversion. Dissolution is evaluated in two stages per USP <711>: 0.1 M hydrochloric acid for 2 h with not more than 10% drug release, then pH 6.8 phosphate buffer at 37 °C with quantitative release. Related substances are determined by liquid chromatography with UV detection at 210 nm; residual methanol from the esterification route is controlled as a Class 2 solvent per ICH Q3C. Content uniformity complies with USP <905>; water content by Karl Fischer is maintained below 0.5%. The bulk API is packed in double polyethylene liners with desiccant and stored at 15–25 °C because the compound sublimes above ambient headspace and can form crystalline deposits on container closures. Production-scale failures are observed when granulation moisture exceeds 1.5% or when the coating dispersion is applied faster than 0.20 kg/min per 48-inch pan, producing tacky tablets and inconsistent acid resistance.
| Quality parameter | Method/standard | Acceptance criterion |
|---|---|---|
| Assay (anhydrous basis) | HPLC, USP <621> | 98.0–102.0% |
| Residual methanol | GC headspace, ICH Q3C | ≤ 0.3% (w/w) |
| Water | Karl Fischer, USP <921> | ≤ 0.5% |
| Residue on ignition | USP <281> | ≤ 0.1% |
For articles intended for the EU market, the placing on the market of dimethyl fumarate in articles or components is prohibited above 0.1 mg/kg per REACH Annex XVII entry 61. The former industrial practice was to dose 0.1–1.0 g of crystalline dimethyl fumarate into permeable nonwoven sachets containing silica gel; sublimation at ambient temperature generated a fungistatic headspace effective against Aspergillus niger, Penicillium commune, and Trichoderma viride in closed shipping containers. The active vapour adsorbed onto leather surfaces and inhibited fungal growth under sustained relative humidity above 75%. The same sublimation property caused severe skin sensitization when the compound migrated from treated upholstery through clothing; outbreaks traced to footwear and sofas led to Regulation (EU) No 412/2012 and the current restriction threshold. Analytical enforcement uses solvent extraction followed by LC-MS/MS, with a reporting limit of 0.05 mg/kg and a decision limit of 0.1 mg/kg. Outside the EU, preservation formulations may still be specified for long-haul container shipments, but exporters must physically segregate treated articles and documentation must be maintained to prevent cross-contamination. On production lines, the compound's volatility requires closed dosing, vacuum transfer, and local exhaust ventilation because the airborne dust and vapour exposure limit is not an OEL but a dermal sensitization threshold far below visible dust levels. A significant process bottleneck is the non-uniform sublimation rate across a 40-foot container: headspace concentration varies with sachet loading, polymer permeability, leather moisture, and ambient temperature cycle, and published data for this specific configuration is limited. Dedicated dosing equipment and washdown verification below 0.1 mg/kg by LC-MS/MS are mandatory for any facility handling both dimethyl fumarate and EU-bound consumer goods.
Dimethyl fumarate functions as a dienophile in Diels–Alder cycloadditions with 1,3-butadiene, cyclopentadiene, and substituted dienes to yield dimethyl cyclohex-4-ene-1,2-dicarboxylate and related intermediates for polyester polyols and alkyd building blocks. The reaction is typically conducted in toluene or xylene at 110–130 °C for 12–20 h under autogenous pressure when 1,3-butadiene is used; cyclopentadiene additions proceed at 60–80 °C because the diene is more reactive and its boiling point is 42 °C. The cyclopentadiene addition favors the endo adduct under kinetic control, and the stereochemical outcome is confirmed by 1H NMR coupling constants rather than by infrared alone. The crude product is cooled, washed with 5% sodium bicarbonate to remove monomethyl fumarate acid intermediate, and distilled under vacuum. Strict exclusion of water and base is essential because dimethyl fumarate hydrolyzes to monomethyl fumarate and methanol, reducing isolated yield and contaminating the ester with an acid-functional impurity. Glass-lined reactors with anchor agitation and a returning condenser for unreacted diene are preferred; oxygen must be kept below 0.5 vol% in the nitrogen blanket to avoid diene peroxide formation. With cyclopentadiene, dicyclopentadiene is cracked at 170–200 °C before charging, and the diene is fed at 1.02–1.10 mol per mole of dimethyl fumarate to limit oligomerization. Continuous-flow processing has been reported at laboratory scale to reduce residence time from hours to minutes, but published data for this specific configuration is limited. The isolated diester is stabilized with 50–100 ppm hydroquinone monomethyl ether before storage to prevent radical polymerization of the residual unsaturation.
Catalytic hydrogenation of dimethyl fumarate to dimethyl succinate is carried out in a fixed-bed reactor over Raney nickel or supported nickel catalysts at 80–120 °C and hydrogen partial pressure of 2.0–5.0 MPa. The molten dimethyl fumarate is fed from a steam-jacketed melt tank at 110–120 °C because its melting point is 103–104 °C; lines are traced at 115 °C to prevent solidification. The reaction is strongly exothermic, with adiabatic temperature rise sufficient to exceed 150 °C across a full conversion bed if not controlled; therefore the catalyst bed is split into two or three zones with interstage cooling. Liquid hourly space velocity is usually held at 0.5–2.0 h−1, and the molar hydrogen-to-ester ratio is maintained above 3.0 to suppress carbon deposition although excess hydrogen increases compression costs. Feed purity is specified at minimum 99.0% dimethyl fumarate with sulfur and chloride below 10 mg/kg to limit nickel catalyst deactivation. The reactor is constructed from 316L stainless steel with length-to-diameter ratio 6:1 to 10:1; hydrogen detection alarms are set at 10% lower explosive limit. The outlet is cooled to 40 °C and separated in a high-pressure knockout drum; unreacted hydrogen is recycled through a methane purge to prevent inert accumulation above 2.0 vol%. Dimethyl succinate is then purified by vacuum distillation at 195–200 °C under reduced pressure to avoid thermal decomposition. This intermediate is a feedstock for transesterification with 1,4-butanediol in polybutylene succinate synthesis and for conversion to 1,4-butanediol via hydrogenolysis. Moisture in the feed must stay below 0.1 wt% because water promotes free methanol generation, which distributes into the hydrogen recycle stream and reduces catalyst wetting characteristics.
Dimethyl fumarate can be copolymerized with vinyl acetate, styrene, and alkyl vinyl ethers by free-radical initiation to introduce ester functionality and reduce crystallinity in select copolymer systems. The electron-poor double bond produces a strong alternating tendency with electron-rich vinyl monomers; reactivity ratios for the styrene system place dimethyl fumarate in the acceptor region, but published data for this specific configuration is limited to laboratory-scale polymerizations. For bulk copolymerization with styrene at 60–80 °C using 0.5–1.0 mol% azobisisobutyronitrile, the resulting copolymers show an upward shift in glass transition temperature as fumarate content increases because the dimethyl ester side groups restrict main-chain motion. The homopolymerization of dimethyl fumarate is not industrially relevant due to a low ceiling temperature and slow propagation rate; therefore it is rarely used as the sole monomer. In reactive compounding, the solid monomer is pre-melted at 110 °C and fed as a liquid into a twin-screw extruder with an L/D ratio of 40:1 and zone temperatures of 120–160 °C; vent port vacuum below 8.0 kPa is required to strip residual methanol and protect surface gloss. Feeding dimethyl fumarate above 20 mol% with styrene broadens the molecular weight distribution significantly, and polymerization at temperatures above 90 °C increases gel formation due to chain transfer to polymer. The skin-sensitizing character of dimethyl fumarate mandates closed-transfer systems, local exhaust ventilation, and dermal exposure controls at compounding lines. Because residual fumarate monomer in extruded pellets can cause occupational dermatitis, pellets are analyzed by gas chromatography after methanol extraction, with a release limit of 50 ppm monomer. This polymer application is not the dominant outlet for dimethyl fumarate; maleic anhydride and diethyl fumarate are often selected instead because the dimethyl ester is a solid with lower solubility in common vinyl monomers.
Chemical derivatization of dimethyl fumarate via partial hydrolysis or transesterification provides monomethyl fumarate, unsymmetrical fumarate esters, and fumaric acid for pharmaceutical and polymer intermediates. Partial saponification in aqueous methanol with sodium hydroxide at pH 9–10 followed by neutralization and crystallization at 5 °C yields monomethyl fumarate; the first ester group hydrolyzes exothermically, while the second ester group is substantially slower because the carboxylate anion deactivates the adjacent carbonyl toward further nucleophilic attack. Process control uses inline pH measurement and jacketed cooling to maintain the reaction at or below 40 °C, because methanol loss above that temperature reduces reproducibility and fumaric acid precipitation complicates separation. The crystalline monoester is isolated by centrifugation and dried in a vacuum tray dryer at 45 °C for 8 h to a loss on drying below 0.5%. Residual dimethyl fumarate in monomethyl fumarate is controlled by HPLC to below 0.1 area percent to protect downstream drug substance purity. Complete hydrolysis with hydrochloric acid at reflux converts dimethyl fumarate to fumaric acid, which is then re-esterified with ethanol, n-butanol, or 2-ethylhexanol to yield dialkyl fumarates used as reactive diluents in ultraviolet-curable coatings and unsaturated polyester resins. Transesterification is catalyzed by tetrabutyl titanate at 120–160 °C with methanol removal through a packed column. Because dimethyl fumarate sublimes and is a skin sensitizer, multi-purpose plants must clean equipment by hot methanol reflux followed by water rinse and verify residues below 10 ppm of the next product by rinse sampling. The unsymmetrical fumarate esters produced from monomethyl fumarate are used as intermediates for esterification with 1,4-butanediol or as derivatization handles in pharmaceutical conjugate synthesis; storage of these esters at or below 8 °C retards premature transesterification and hydrolysis.
Competitive Dimethyl Fumarate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615380400285 or mail to admin@maleic-anhydride.net.
We will respond to you as soon as possible.
Tel: +8615380400285
Email: admin@maleic-anhydride.net
Flexible payment, competitive price, premium service - Inquire now!
Dimethyl fumarate (CAS 624-49-7, C6H8O4, molar mass 144.13 g/mol) is the trans-methyl ester of fumaric acid. The compound is manufactured by methanolic esterification of fumaric acid under acid catalysis, with preservation of the trans geometry during distillation. It is supplied as a white to off-white crystalline solid with a melting range of 102–105 °C, boiling point 192–193 °C at standard pressure, and relative density approximately 1.37 g/cm3 at 20 °C. Industrial ordering does not rely on a universal model code; the material is specified by CAS registration, grade (pharmaceutical intermediate, polymer monomer, or synthesis dienophile), and residual impurity profile. Suppliers may use internal product codes, but these are not standardized and must be verified against the certificate of analysis.
In pharmaceutical use, the approved oral product is supplied as delayed-release capsules containing 120 mg or 240 mg dimethyl fumarate. The starting dose is 120 mg twice daily for 7 days, followed by 240 mg twice daily; administration with food reduces flushing but does not eliminate it. The proposed mechanism involves alkylation of critical cysteine residues on Kelch-like ECH-associated protein 1, stabilization of nuclear factor erythroid 2–related factor 2, and transcription of antioxidant response elements; this pathway is supported by in vitro assays but the precise clinical mechanism is not fully established. Intact dimethyl fumarate is not reliably detected in plasma after oral dosing because of rapid esterase-mediated hydrolysis to monomethyl fumarate, which is the principal active metabolite. Within multiple sclerosis therapy, dimethyl fumarate is an oral small molecule and is distinguished from injectable interferon beta products and monoclonal antibodies by route of administration and by small-molecule control strategies rather than cell-based potency assays.
Aqueous systems are a critical boundary for dimethyl fumarate. The two methyl ester groups undergo pH-dependent hydrolysis to monomethyl fumarate and methanol, followed by slower conversion to fumaric acid. At pH above 5 and temperature above 35 °C, the rate accelerates; this restricts liquid oral dosage forms and wet granulation processes. For development batches, dimethyl fumarate suspended in water at 25 °C shows ester impurity increase over 24 h, while methanolic or acetone-based granulation fluids reduce hydrolysis but introduce residual solvent controls under ICH Q3C (R8).
During solid dosage form manufacture, wet granulation is a recognized processing conflict because water introduced at 25–30 °C can raise total related substances above the 1.0% release limit. Production-scale batches therefore use direct compression or dry granulation. A typical dry granulation configuration uses a Gerteis Mini-Pactor with roll force 4–8 kN/cm and gap 1.0–2.0 mm, followed by compression on a rotary tablet press at 12–18 kN main compression force to target hardness 80–120 N. Residual moisture is measured by Karl Fischer and held below 0.5% before encapsulation. Batches manufactured under ambient relative humidity above 60% without desiccant show increased hydrolysis and variable dissolution; therefore humidity-controlled suites with dew point below 8 °C are specified for dispensing.
Release of pharmaceutical-grade dimethyl fumarate is governed by small-molecule compendial and cGMP requirements under 21 CFR 211 and ICH Q7A. Table 1 lists a typical specification profile aligned with USP-NF and Ph. Eur. approaches; suppliers may tighten individual limits for dedicated multiple sclerosis capsule manufacturing.
| Parameter | Acceptance criterion | Test standard |
|---|---|---|
| Appearance | White to off-white crystalline powder | Visual examination |
| Identification | Infrared spectrum matches dimethyl fumarate reference | Ph. Eur. 2.2.24 |
| Assay, anhydrous basis | 98.0–102.0% | HPLC, USP <621> |
| Dimethyl maleate | ≤0.5% | HPLC |
| Any unspecified impurity | ≤0.10% | HPLC |
| Total impurities | ≤1.0% | HPLC |
| Water content | ≤0.5% | Karl Fischer, USP <921> Method Ia |
| Residue on ignition | ≤0.1% | USP <281> |
| Elemental impurities | Meets ICH Q3D Option 1 | USP <232>/<233> |
| Melting range | 102–105 °C | USP <741> |
| Residual solvents | Meets ICH Q3C (R8) | USP <467> |
Routine HPLC uses a C18 column with a mobile phase of acetonitrile and phosphate buffer at pH 3.0, detection at 210 nm. Dimethyl maleate and fumarate isomers are resolved to a minimum resolution of 2.0; the assay is linear over a range covering 80–120% of nominal concentration, with system precision below 2.0% RSD.
For product selection, the trans geometry separates dimethyl fumarate from its cis isomer, its higher esters, and its monoester metabolite. Dimethyl maleate is a liquid at room temperature and has different stereoelectronic behaviour; the trans geometry of dimethyl fumarate gives a crystalline solid that is easier to purify by recrystallization from methanol/water. Monomethyl fumarate carries a free carboxylic acid, giving pH-dependent aqueous solubility and lower passive permeability than the dimethyl ester. Diethyl fumarate has higher molar mass and lower melting point, which changes migration kinetics in polymer matrices and volatility during thermal processing. Table 2 summarizes the comparative values used in formulation and polymer screening.
| Property | Dimethyl fumarate | Dimethyl maleate | Diethyl fumarate | Monomethyl fumarate |
|---|---|---|---|---|
| CAS RN | 624-49-7 | 624-48-6 | 623-91-6 | 2756-87-8 |
| Molar mass, g/mol | 144.13 | 144.13 | 172.18 | 130.10 |
| Configuration | trans (E) | cis (Z) | trans (E) | trans (E), monoester |
| Physical state at 25 °C | Crystalline solid | Liquid | Liquid | Crystalline solid |
| Melting range, °C | 102–105 | -17 | 1–2 | 144–145 |
| Key function | Pharmaceutical API; Diels-Alder dienophile | Plasticizer intermediate; Diels-Alder dienophile | Polymer intermediate; fragrance intermediate | Active metabolite; investigational API |
| Regulatory status | REACH Annex XVII entry 61 article limit 0.1 mg/kg | Not subject to same article restriction | Not subject to same article restriction | Metabolite in dimethyl fumarate-treated patients |
In polyester and Diels-Alder applications, the electron-deficient alkene of dimethyl fumarate controls reactivity. In unsaturated polyester resin modification, the trans ester is less prone to intramolecular anhydride formation during high-temperature cure than maleate-derived unsaturated polyester intermediates. This reduces premature chain termination and can extend gel time when dimethyl fumarate is used as a reactive diluent at 2–10 wt% relative to resin. Cure exotherms measured by differential scanning calorimetry at 10 °C/min show onset shifts; published data for this specific configuration is limited, and individual resin systems require peroxide initiator and inhibitor levels to be re-optimized. In twin-screw compounding with styrene, the feed throat must be nitrogen-blanketed and moisture held below 0.05% because hydrolysis-derived monomethyl fumarate can carboxylate screws and degrade melt stability.
Because dimethyl fumarate is a dermal and respiratory sensitizer, containment at source with local exhaust ventilation and chemical protective gloves tested according to EN ISO 374-1:2016 is required. EU REACH Annex XVII entry 61 restricts its presence in articles or parts thereof to 0.1 mg/kg because of allergic contact dermatitis outbreaks linked to leather furniture and footwear; this restriction follows Commission Decision 2009/251/EC, which required withdrawal of consumer articles containing dimethyl fumarate. It is incompatible with primary amines and alkaline aqueous media due to Michael addition and rapid ester hydrolysis. Bulk storage is specified at 15–25 °C in sealed HDPE drums with desiccant; storage above 50% relative humidity is to be avoided unless the package is resealed under nitrogen.
Above 160 °C, dimethyl fumarate becomes sensitive to residual peroxides and moisture. Free-radical initiator residues can add to the activated double bond, leading to oligomer formation and crosslinked gels in the feed zone. The processing window for dimethyl fumarate as a comonomer is therefore narrow: barrel temperatures between 140 and 180 °C with residence time below 90 s are typical for twin-screw extrusion with L/D 40:1; excursions above 180 °C are associated with colour development and torque fluctuation. Pre-drying to 0.05% moisture by Karl Fischer is specified when the resin contains styrene because hydrolysis-generated methanol promotes phase separation and acid-catalyzed styrene oligomerization. Published data for this specific configuration is limited; the described boundary is based on production-scale campaigns with styrene-containing systems.